Group 1 - Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. regarding potential securities fraud or unlawful business practices by the company and its officers [1] - Blue Orca Capital issued a short report alleging that Nutex faces litigation risk due to its relationship with HaloMD, which is involved in a fraudulent scheme against insurance companies [2] - Following the release of the Blue Orca report, Nutex's stock price dropped by $11.18 per share, a decrease of 10.05%, closing at $100.01 per share on July 22, 2025 [3] Group 2 - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for victims of securities fraud [4]

Core Viewpoint - Nutex Health Inc. has faced significant share price decline following a critical report from Blue Orca Capital, which raised concerns about the company's practices related to independent dispute resolution vendor HaloMD and its financial health [1][5]. Group 1: Financial Performance and Revenue Recognition - Nutex reported a decline in average payments by insurers for adjudicated patient claims for emergency services, with a decrease of approximately 26% at the end of 2022 and about 19% at the end of 2023 [4]. - The company refined its revenue recognition timing, which resulted in an increase of approximately $169.7 million in revenue and $112.0 million in net income before tax for the year ended December 31, 2024 [5]. Group 2: Legal and Regulatory Issues - Blue Orca Capital's report has prompted Hagens Berman to investigate whether Nutex misled investors regarding its compliance with the No Surprises Act and the propriety of its actions [2][6]. - The report highlighted that Nutex's IDR vendor, HaloMD, is facing serious allegations, including theft, fraud, and racketeering, which could pose significant risks to Nutex [5]. Group 3: Market Position and Future Outlook - Blue Orca Capital expressed concerns that Nutex may revert to penny stock status, citing substantial operating and net losses in 2022 and 2023, which led to a market capitalization of less than $30 million [5]. - The report suggested that a majority of Nutex's recognized revenue may be uncollectible, indicating a precarious financial position for the company [5].

Company Overview - Nutex Health Inc. is a healthcare services company that develops and operates micro-hospitals and outpatient facilities, manages independent physician associations through a cloud-based platform, and owns and leases healthcare real estate across the United States [2]. Allegations and Concerns - On July 22, 2025, short seller Blue Orca Capital published a report raising concerns about Nutex's relationship with HaloMD, a third-party vendor recently sued for allegedly engaging in a "coordinated fraudulent scheme" to defraud insurance companies [3]. - The report claims that HaloMD assisted Nutex in generating "unsustainably high" reimbursement rates through the arbitration process outlined in the No Surprises Act (NSA), which is designed to protect patients from unexpected medical bills [3]. Market Reaction - Following the publication of the Blue Orca report, Nutex's stock price fell by $11.18 per share, or 10.05%, closing at $100.01 per share on July 22, 2025 [4].

Core Viewpoint - Nutex Health Inc. is under investigation for possible securities fraud following allegations raised by Blue Orca Capital regarding its billing practices, which have led to a significant decline in its stock price [3][4]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm has initiated an investigation into Nutex Health Inc. and may file a class action on behalf of investors who have incurred losses [1]. - Investors are encouraged to contact attorney Lesley F. Portnoy for a complimentary case evaluation and to discuss their legal rights [2]. Group 2: Allegations and Impact - Blue Orca Capital published a report on July 22, 2025, alleging that Nutex's stock price surged due to routing out-of-network medical billing claims through arbitration with a previously undisclosed third-party vendor [3]. - The vendor identified in the report is HaloHD, which has been implicated in multiple lawsuits for allegedly participating in fraudulent schemes to extract funds from insurance companies [4]. - Following the report's release, Nutex's share price fell by $11.18, approximately 10.1%, closing at $100.01 per share, resulting in significant losses for investors [4].

Core Points - A securities class action lawsuit has been filed against Fluence Energy, Inc. for the period from October 28, 2021, to February 10, 2025 [1][2] - The lawsuit follows a report from Blue Orca Capital revealing that Siemens had sued Fluence for misrepresentation, breach of contract, and fraud [2] - Following the news of the Siemens lawsuit, Fluence's stock price dropped over 13%, from $17.01 to $14.73 per share [3] - On February 10, 2025, Fluence reported a Q1 fiscal 2025 net loss of $57 million, with revenues down 49% year-over-year, and subsequently lowered revenue guidance [3] - The stock price fell further by $6.07, or more than 46%, from $13.07 to $7.00 per share on February 11, 2025 [4] Legal Context - Investors who purchased Fluence securities during the class period have until May 12, 2025, to seek appointment as lead plaintiff [2] - A lead plaintiff represents the interests of all class members in the litigation process [5] - Berger Montague has a long history in securities class action litigation, representing both individual and institutional investors [6]

Core Viewpoint - Fluence Energy, Inc. is facing a class action lawsuit due to allegations of misleading statements and undisclosed product defects that have led to significant financial losses for investors [1][3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit against Fluence Energy involves purchasers of its Class A common stock from October 28, 2021, to February 10, 2025, with a deadline for lead plaintiff applications set for May 12, 2025 [1]. - The lawsuit alleges that Fluence Energy and its executives violated the Securities Exchange Act of 1934 by making false statements regarding the quality and performance of their energy storage products [3][4]. - Specific allegations include defective design and operational issues with products, failure to address known defects, and overstated financial metrics such as adjusted EBITDA and gross profit margins [3]. Group 2: Product and Project Failures - Reports have surfaced detailing significant defects in Fluence Energy's Diablo project, including slow response times of project control systems and multiple failures of inverters, leading to operational inefficiencies and safety risks [4]. - The Diablo project was delivered eight months late, and Fluence Energy failed to resolve warranty claims in a timely manner, contributing to reputational damage [4]. - A research report from Blue Orca Capital indicated that Fluence Energy sold its sixth-generation technology prematurely, which exacerbated operational issues [5]. Group 3: Financial Performance and Stock Impact - Fluence Energy's financial guidance for fiscal 2025 was revised down from $3.6 billion to $4.4 billion to a new range of $3.1 billion to $3.7 billion, reflecting a reduction of approximately $600 million at the midpoint due to customer-driven delays and competitive pressures [7]. - The company reported quarterly revenue of $187 million, which missed consensus estimates by nearly 48%, leading to a significant stock price drop of over 52% in a three-day trading period [7]. - Prior to this, the company had already seen its stock price fall approximately 22% following the release of its annual revenue guidance, indicating a lack of sufficient contracted work to meet targets [6].

Core Viewpoint - A lawsuit has been filed against Fluence Energy, Inc. and certain senior executives for potential violations of federal securities laws, alleging misrepresentation of the company's competitive position and financial performance [1][2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Eastern District of Virginia, captioned Abramov v. Fluence Energy, Inc., et al., No. 25-cv-00444, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until May 12, 2025, to request to be appointed to lead the case [2]. Group 2: Company Background - Fluence Energy specializes in energy storage products and solutions, delivery services, operational and maintenance services, and digital applications for energy storage and power assets [3]. Group 3: Allegations and Financial Impact - Allegations include that Fluence Energy misrepresented its sales pipeline and backlog, concealing declines in sales and earnings growth through aggressive revenue pull-forwards and selective earnings adjustments [4]. - A report by Blue Orca Capital revealed that Siemens Energy filed a lawsuit against Fluence Energy for misrepresentations and fraud, which contributed to a significant decline in stock price [5]. - In Q1 2025, Fluence Energy reported a net loss of $57 million, or $0.32 per share, with revenues falling 49% year-over-year, leading to a 46% drop in stock price to $7.00 per share [6].

Core Viewpoint - Fluence Energy, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements and undisclosed product defects impacting its financial performance and reputation [1][3]. Company Allegations - The lawsuit alleges that Fluence Energy's energy storage products had significant design and operational defects, which were not adequately addressed, leading to inflated financial metrics [3]. - Specific issues cited include defective product designs, failure to honor warranty obligations, and overstated efficacy and safety of products [3]. Project Issues - The Diablo project faced numerous defects, including slow response times in project control systems and multiple failures of inverters, leading to operational inefficiencies and safety risks [4]. - Fluence Energy delivered the Diablo project eight months late and failed to resolve warranty claims in a timely manner, contributing to a significant drop in stock price [4]. Financial Performance - In the fourth quarter of 2024, Fluence Energy projected annual revenue for fiscal 2025 between $3.6 billion and $4.4 billion, but only 65% of this was backed by current contracts, indicating a need for new orders [6]. - The company later revised its fiscal 2025 revenue guidance down to a range of $3.1 billion to $3.7 billion, a reduction of approximately $600 million, due to customer-driven delays and competitive pressures [7]. - Quarterly revenue for the first fiscal quarter of 2025 was reported at $187 million, missing consensus estimates by nearly 48%, leading to a significant decline in stock price [7].

PHILADELPHIA, May 01, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Fluence Energy, Inc. (“Fluence” or the “Company”) (NASDAQ: FLNC) on behalf of purchasers of Fluence securities between October 28, 2021 through February 10, 2025, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired Fluence securities during the Class Period may, no later than MAY 12, 2025, seek to be appointed as a lead plaintiff ...

Core Viewpoint - A lawsuit has been filed against Fluence Energy, Inc. and its senior executives for potential violations of federal securities laws, alleging misrepresentation of the company's competitive position and financial performance [1][2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Eastern District of Virginia, titled Abramov v. Fluence Energy, Inc., et al., No. 25-cv-00444, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until May 12, 2025, to request to be appointed to lead the case [2]. Group 2: Allegations Against Fluence Energy - Fluence Energy is accused of misrepresenting its sales pipeline and backlog of orders, concealing declines in sales and earnings growth through aggressive revenue pull-forwards and selective earnings adjustments [4][5]. - A report by Blue Orca Capital revealed that Siemens Energy, a major revenue source for Fluence, filed a lawsuit against the company for misrepresentations and fraud [5]. Group 3: Financial Performance - In Q1 2025, Fluence Energy reported a net loss of $57 million, or $0.32 per share, with revenues falling 49% year-over-year, leading to a 46% decline in stock price to $7.00 per share [6]. - The company attributed the revenue decline to customer-driven delays in contract signings and competitive pressures, prompting a lowered revenue outlook for the fiscal year 2025 [6].